FDA Submits Collection of Information for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in response to a comment request regarding the impact of spousal influence on consumer understanding and response to direct-to-consumer prescription drug advertisements.